Author:
Ortmann Olaf,Emons Günter,Tempfer Clemens
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology
Reference58 articles.
1. DGGG (2019) Peri- and Postmenopause—Diagnosis and Interventions. Guideline of the German Society of Gynecology and Obstetrics (S‑3 Level, AWMF Registry No. 015-062, June 2019).
http://www.awmf.org/leitlinien/detail/ll/015-062.html
. Zugegriffen: 31. Juli 2019
2. Buchholz S, Ortmann O (2014) Weitere Tumoren und Endokrinium. In: Leidenberger F, Strowitzki T, Ortmann O (Hrsg) Klinische Endokrinologie für Frauenärzte. Springer, Berlin
3. Mills PK, Beeson WL, Phillips RL, Fraser GE (1989) Prospective study of exogenous hormone use and breast cancer in Seventh-day Adventists. Cancer 64:591–597
4. Colditz GA, Stampfer MJ, Willett WC et al (1992) Type of postmenopausal hormone use and risk of breast cancer: 12-year follow-up from the Nurses’ Health Study. Cancer Causes Control 3:433–439
5. Folso AR, Mink PJ, Sellers TA et al (1995) Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women. Am J Public Health 85:1128–1132
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Hormonersatztherapie und Krebsrisiko;Journal für Gynäkologische Endokrinologie/Österreich;2020-09